Quick Order Cart

Cat. No. ARG27734

ABCB8 Knockout huh-7 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Hepatocellular carcinoma

The ABCB8 Knockout Huh-7 Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal knockout population in the human Huh-7 hepatoma cell line for studying mitochondrial iron transporter ABCB8. This model enables investigation of iron homeostasis, heme biosynthesis, and ferroptosis resistance in a hepatic cancer context. ABCB8 exports mitochondrial iron, regulated by NRF2 and interacting with HSPA9 and ferrochelatase. Applications include ICP-MS iron quantification, ROS detection, heme synthesis assays, and ferroptosis analyses with lipid peroxidation and GPX4 activity measurements.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Huh-7

    Sex of Donor

    Male

    Age

    57 years

    Gene Name

    ABCB8

    Gene Identifier

    NCBI Gene ID 11194

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ABCB8 Knockout Huh-7 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal knockout cell population in which the ABCB8 gene has been disrupted in the Huh-7 human hepatocellular carcinoma cell line. This polyclonal pool provides a genetically diverse loss-of-function model suitable for studying ABCB8 biology without clonal selection biases.

Huh-7 is a well-established adherent epithelial cell line derived from a liver tumor of a 57-year-old Japanese male. It serves as a widely used model for hepatocellular carcinoma, hepatocyte function, and viral hepatitis research, offering a hepatic context for investigating iron metabolism, oxidative stress, and drug responses.

ABCB8 encodes a mitochondrial inner membrane transporter that exports iron from the matrix to the intermembrane space, facilitating heme biosynthesis and protecting against mitochondrial iron overload and oxidative stress. Its activity is modulated by iron status, heme, doxorubicin, and the transcription factor NRF2. Downstream, ABCB8 influences mitochondrial iron levels, heme synthesis, ROS production, cytosolic iron-sulfur cluster assembly, and ferroptosis resistance. It interacts with mitochondrial iron-sulfur cluster assembly proteins, heme biosynthetic enzymes, and the chaperone HSPA9. Key pathway components include mitoferrin (SLC25A37), ABCB7, frataxin, ferrochelatase, and IRP1/IRP2. Disruption of ABCB8 leads to mitochondrial iron accumulation and heightened oxidative vulnerability.

In Huh-7 hepatoma cells, ABCB8 knockout creates a relevant model for exploring mitochondrial iron homeostasis in liver cancer. Hepatocytes are central to iron regulation and susceptible to ferroptosis, an iron-dependent cell death implicated in liver disease and cancer therapy. This model allows investigation of ABCB8-dependent modulation of tumor cell survival, drug sensitivity, and metabolic reprogramming, as well as mechanisms of doxorubicin-induced toxicity.

This polyclonal knockout population supports applications in mitochondrial iron homeostasis, heme biosynthesis, and ferroptosis research using assays such as ICP-MS for iron quantification, Western blotting, ROS detection, heme synthesis assays, and cell viability tests under oxidative stress. Additional ferroptosis-focused assays include lipid peroxidation and GPX4 activity measurements. The model is also suited for drug testing and hepatotoxicity studies. For further details, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)